Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Twist Bioscience Corp
(NQ:
TWST
)
43.24
-1.66 (-3.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Twist Bioscience Corp
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Twist Bioscience Q3 Sales Jump 60%, Raises FY22 Revenue Outlook Surpassing Consensus
August 05, 2022
Via
Benzinga
Recap: Twist Bioscience Q3 Earnings
August 05, 2022
Twist Bioscience (NASDAQ:TWST) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results
August 05, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Earnings Preview
August 04, 2022
Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Twist...
Via
Benzinga
Twist Bioscience to Present at Flash Memory Summit
August 03, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls For Developing Assays
July 14, 2022
Via
Benzinga
Earnings Scheduled For August 5, 2022
August 05, 2022
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 02, 2022
Via
Benzinga
Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
August 02, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
August 02, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
August 01, 2022
From
Twist Bioscience Corporation
Via
Business Wire
5 Top Stocks Cathie Wood Bought This Week
July 21, 2022
Shares of ARKK are up about 20% the past month as Cathie Wood continues her highly-convicted purchases of growth stocks.
Via
InvestorPlace
Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
July 18, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
July 14, 2022
From
Twist Bioscience Corporation
Via
Business Wire
DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow
July 13, 2022
From
DNAnexus, Inc.
Via
Business Wire
7 Best Biotech Stocks to Buy in July 2022
July 08, 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.
Via
InvestorPlace
Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity
July 06, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
June 30, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
June 16, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
June 13, 2022
During Monday's trading, 1214 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
June 14, 2022
On Tuesday, 951 companies hit new 52-week lows.
Via
Benzinga
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening
June 07, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
June 02, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications
May 31, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
May 18, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit
May 10, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
May 09, 2022
Via
Benzinga
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
May 09, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Second Quarter 2022 Financial Results
May 05, 2022
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience's Earnings: A Preview
May 04, 2022
Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Twist...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.